FDA Inspection 1217117 — Astellas Pharma US Inc.
The FDA completed an inspection of Astellas Pharma US Inc. on Aug 14, 2023 in Northbrook, IL. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Aug 14, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Northbrook, IL (United States)
Additional Details
Sponsor, Contract Research Organization